Oslo-based Nordic Nanovector ASA added Rainer Boehm to its board of directors.
Boehm was previously chief commercial and medical affairs officer at Novartis Pharma in Switzerland.
Nordic Nanovector develops therapies for blood cancers.
Nordic Nanovector adds board member
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Oslo-based Nordic Nanovector ASA added Rainer Boehm to its board of directors.
Boehm was previously chief commercial and medical affairs officer at Novartis Pharma in Switzerland.
Nordic Nanovector develops therapies for blood cancers.